Biosurgery has opened a replacement paradigm in surgical care, wound and tissue management, and regenerative healing. The varied products underneath biosurgery have generated vast interest among surgeons and patient alike and are expected to realize traction in numerous medical specialties including orthopaedic, gynaecology, cardiovascular, neurosurgery and spine-related treatments. Biosurgery has unlocked new potential in regenerative healing with the proper mixture of biologics and synthetics. The biosurgery market is predicted to profit from ample latent opportunities in growing number of surgeries, world over. An outsized number of surgeries are related to sports related activities and severe trauma injuries.
The global Biosurgery Market Expected to Exceed more than US$ 9.60 Billion by 2028 at a CAGR of 6.7%.
The market also will garner noticeable gains from the rapidly aging population in several emerging countries. The increasing necessity for advanced biomaterials for intra-operative wound and tissue management could even be a prominent trend boosting the universal biosurgery market. Life sciences companies developing products for surgical care are increasingly focused on exploring new avenues in biosurgery by engaging in relentless research and development activities.
Global Biosurgery market is segmented based on the Application as, Orthopedic, Gynecology, Cardiovascular, Reconstructive. Global Biosurgery market is segmented based on the Product as, Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes.
Global Biosurgery market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Biosurgery market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Research Methodology:
To calculate the market size, the report considers the revenue generated from the sales of Biosurgery market manufacturers. The revenue generated from the sales of Biosurgery manufacturer has been calculated through primary and secondary research.
The market size estimation also considered leading players revenues as part of triangulation the key players considered are Baxter International (US), Johnson & Johnson (J&J) (US), Medtronic plc (Ireland), Sanofi (France), C.R. Bard (US), Integra LifeSciences (US), and Maquet holdings (Sweden), lead the global biosurgery market. Some of the other leading players in this market include Cohera Medical (US), Hemostasis LLC. (US), Stryker Corporation (US), B.Braun Melsungen AG (Germany), CSL Limited (Australia), Pfizer Inc. (US), and Cryolife Inc. (US) Availability Services among others operating in the Biosurgery market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes types of segmentation determined using secondary sources and verified through primary sources.
The Biosurgery Market has been segmented as below:
Biosurgery Market, By Extract Process
Biosurgery Market, Application
Biosurgery Market, By Region
Report scope:
The global Biosurgery market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends. The report scope includes market analysis on regional as well as country level.
Reasons to Buy this Report:
Below are our New Reports :-
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1. Secondary Research
2.3.2. Primary Research
2.3.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
3. Executive Summary
4. Biosurgery Market, By Product
4.1. Key Points
4.2. Surgical Sealants and adhesives
4.2.1. Natural/Biological Sealants, By Type
4.2.1.1. Fibrin Sealants
4.2.1.1.1. Market Overview
4.2.1.1.2. Market Size & Forecast
4.2.1.2. Collagen Based Sealants
4.2.1.2.1. Market Overview
4.2.1.2.2. Market Size & Forecast
4.2.1.3. Gelatin Based Sealants
4.2.1.3.1. Market Overview
4.2.1.3.2. Market Size & Forecast
4.2.1.4. Albumin Based Sealants
4.2.1.4.1. Market Overview
4.2.1.4.2. Market Size & Forecast
4.2.1.5. Others
4.2.1.5.1. Market Overview
4.2.1.5.2. Market Size & Forecast
4.2.2. Natural/Biological Sealants
4.2.2.1. Human Blood Based
4.2.2.1.1. Market Overview
4.2.2.1.2. Market Size & Forecast
4.2.2.2. Animal Based Sealants
4.2.2.2.1. Market Overview
4.2.2.2.2. Market Size & Forecast
4.2.3. Synthetic/Semi-synthetic Sealants
4.2.3.1. Cyanoacrylates
4.2.3.1.1. Market Overview
4.2.3.1.2. Market Size & Forecast
4.2.3.2. Polymeric Hyrogels
4.2.3.2.1. Market Overview
4.2.3.2.2. Market Size & Forecast
4.2.3.3. Urethane-based Sealants
4.2.3.3.1. Market Overview
4.2.3.3.2. Market Size & Forecast
4.2.3.4. Others
4.2.3.4.1. Market Overview
4.2.3.4.2. Market Size & Forecast
4.3. Hemostatic Agents
4.3.1. Thrombin-Based
4.3.1.1. Market Overview
4.3.1.2. Market Size & Forecast
4.3.2. Oxidized Regenerated Cellulose Based Hemostats
4.3.2.1. Market Overview
4.3.2.2. Market Size & Forecast
4.3.3. Combination hemostats
4.3.3.1. Market Overview
4.3.3.2. Market Size & Forecast
4.3.4. Others
4.3.4.1. Market Overview
4.3.4.2. Market Size & Forecast
4.4. Adhesion Barriers
4.4.1. Synthetic Adhesion Barriers
4.4.1.1. Hyaluronic Acid
4.4.1.1.1. Market Overview
4.4.1.1.2. Market Size & Forecast
4.4.1.2. Regenarated Cellulose
4.4.1.2.1. Market Overview
4.4.1.2.2. Market Size & Forecast
4.4.1.3. Polyethylene Glycol (PEG)
4.4.1.3.1. Market Overview
4.4.1.3.2. Market Size & Forecast
4.4.1.4. Others
4.4.1.4.1. Market Overview
4.4.1.4.2. Market Size & Forecast
4.4.2. Natural Adhesion Barriers
4.4.2.1. Collagen & Protein
4.4.2.1.1. Market Overview
4.4.2.1.2. Market Size & Forecast
4.4.2.2. Fibrin Based
4.4.2.2.1. Market Overview
4.4.2.2.2. Market Size & Forecast
4.5. Soft Tissue Attachments
4.5.1. Synthetic Mesh
4.5.1.1. Market Overview
4.5.1.2. Market Size & Forecast
4.5.2. Biological Mesh
4.5.2.1. Allograft
4.5.2.1.1. Market Overview
4.5.2.1.2. Market Size & Forecast
4.5.2.2. Xenograft
4.5.2.2.1. Market Overview
4.5.2.2.2. Market Size & Forecast
4.6. Bone Graft Substitutes
4.6.1. Demineralized Bone Matrix (DBM)
4.6.1.1. Market Overview
4.6.1.2. Market Size & Forecast
4.6.2. Bone Morphogenetic Proteins (BMP)Synthetic Bone Grafts
4.6.2.1. Market Overview
4.6.2.2. Market Size & Forecast
4.6.3. Synthetic Bone Grafts
4.6.3.1. Market Overview
4.6.3.2. Market Size & Forecast
4.6.4. Others
4.6.4.1. Market Overview
4.6.4.2. Market Size & Forecast
4.7. Staple Line Reinforcement Agents
4.7.1. Market Overview
4.7.2. Market Size & Forecast
5. Biosurgery Market, By Application
5.1. Key Points
5.2. Gynecological Surgeries
5.2.1. Market Overview
5.2.2. Market Size & Forecast
5.3. General/Abdominal Surgeries
5.3.1. Market Overview
5.3.2. Market Size & Forecast
5.4. Orthopedic Surgeries
5.4.1. Market Overview
5.4.2. Market Size & Forecast
5.5. Cardiovascular Surgeries
5.5.1. Market Overview
5.5.2. Market Size & Forecast
5.6. Neurological Surgeries
5.6.1. Market Overview
5.6.2. Market Size & Forecast
5.7. Urological Surgeries
5.7.1. Market Overview
5.7.2. Market Size & Forecast
5.8. Reconstructive Surgeries
5.8.1. Market Overview
5.8.2. Market Size & Forecast
5.9. Thoracic Surgeries
5.9.1. Market Overview
5.9.2. Market Size & Forecast
5.10. Other Surgeries
5.10.1. Market Overview
5.10.2. Market Size & Forecast
6. Biosurgery Market, By Region
6.1. North America
6.1.1. North America Industrial Floor Coating, By Product
6.1.2. North America Industrial Floor Coating, By Type
6.1.3. By Country
6.1.3.1. U.S
6.1.3.2. Canada
6.1.3.3. Mexico
6.2. Europe
6.2.1. Europe Industrial Floor Coating, By Extract Process
6.2.2. Europe Industrial Floor Coating, By Application
6.2.3. By Country
6.2.3.1. U.K
6.2.3.2. Germany
6.2.3.3. Italy
6.2.3.4. France
6.2.3.5. Rest of Europe
6.3. Asia Pacific
6.3.1. Asia Pacific Industrial Floor Coating, By Extract Process
6.3.2. Asia Pacific Industrial Floor Coating, By Application
6.3.3. By Country
6.3.3.1. China
6.3.3.2. Australia
6.3.3.3. Japan
6.3.3.4. South Korea
6.3.3.5. India
6.3.3.6. Rest of Asia Pacific
6.4. Rest of World
6.4.1. Rest of World Industrial Floor Coating, By Extract Process
6.4.2. Rest of World Industrial Floor Coating, By Application
The Biosurgery Market has been segmented as below:
Biosurgery Market, By Extract Process
Biosurgery Market, Application
Biosurgery Market, By Region
